Dr. Wilson’s research focuses on building descriptions of the relationships between neurological function, gene product regulation, and disease state in adults who experience neuropsychiatric disease. Neuropsychiatric diseases are complex, and their often-widespread impact on function can make treatment difficult. To get a better understanding of how particular neurological changes may be related to disease symptoms, Dr. Wilson uses artificial intelligence to consider multiple aspects of a patient’s status in combination, including transcriptomic and epigenomic data from various brain regions (which inform about how gene expression is regulated); anatomical data from various brain regions (which can show how cells may change or interact); and clinical data, such as neurological health measures and comorbidity records. By revealing new insights about how genetics, other cell-level changes, environmental factors, and disease progression influence each other in patient populations, this effort aims to ultimately highlight ways to improve therapeutic strategies for these diseases.